Daily as of 3 Nov 16:00 ET
- Price
- between the two $21.48 vs 50 $19.55 / 200 $22.13
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐Death cross 31 Aug 2026 ยท projected 29 bars out
Legend Biotech Corporation (LEGN) is a NASDAQ-listed ADR that Cruxta has tracked for 50/200 crosses since 2021.
The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is below both.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 31 Aug 2026 | ๐Death steep | daily | 29 bars out | Not tested |
| 31 Jul 2026 | ๐Death | 4-hour | 29 bars out | Not tested |
| 11 Jun 2026 | ๐จGolden steep | daily | 27 bars out | 3 bar cross test |
| 29 Apr 2026 | ๐จGolden | 4-hour | 15 bars out | Not tested |
| 9 Oct 2025 | ๐Death steep | daily | 29 bars out | 2 bar cross test |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.